Comorbidities and Events of Clinical Interest in Patients with Pulmonary Arterial Hypertension (PAH): Analysis of Real‐World Data

Key Points

• To examine the prevalence of comorbidities and the incidence of clinical events in patients with pulmonary arterial hypertension.
• Retrospective analysis of a linked claims-EHR cohort in the U.S.
• Included 16,749 patients with pulmonary arterial hypertension.
• Identified prevalence of hypertension, heart failure, diabetes, and chronic kidney disease.
• Calculated incidence rates for thrombocytopenia and major bleeding.
• Hypertension, heart failure, diabetes, and chronic kidney disease were common comorbidities.
• Incidence rates for thrombocytopenia and major bleeding were 8.2 and 7.3 per 100 person-years, respectively.